Huayi Ningchuang

Have updates for this profile? Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Huayi Ningchuang - overview

Established

2015

Location

Ningbo, Zhejiang, China

Primary Industry

Medical Devices & Equipment

About

Founded in 2015 and based in Ningbo, China, Huayi Ningchuang is a scientific instrument company that focuses on the research and development of intelligent life health detection dedicated mass spectrometers. The company has platforms such as Zhejiang Key Laboratory of Advanced Mass Spectrometry Technology and Molecular Detection, Zhejiang Engineering Research Center for Innovative Diagnosis and Treatment of Bladder Cancer, and Ningbo Life Health High-end Equipment Engineering Technology Center. The R&D team has more than 10 years of experience in mass spectrometer research. It has cooperations with Ningbo University, Tsinghua University, Peking University, etc.


In July 2024, Huayi Ningchuang closed a pre-series A+ funding.   The company specializes in developing intelligent instruments for life, health, and safety testing. The products include direct ionization mass spectrometers, food safety detection immune analyzers, biological sample poison detection portable mass spectrometers, and single-cell mass spectrometry analysis systems. The food safety detection immune analyzer provides data storage, sample pretreatment equipment, wireless transmission remote control, report printing and output, and other services.


Its products are used in public security organs, food and drug safety supervision departments, scientific research institutes, and other fields.   The company generates revenue by providing intelligent instruments for life, health, and safety testing. The company will use the pre-series A+ funds for research and development, mass spectrometer medical device certification application, production and manufacturing, laboratory capacity building, and team building. It also plans to start series A financing.


Current Investors

Xiangshuo Equity Investment, Hua Yue

Primary Industry

Medical Devices & Equipment

Sub Industries

Healthcare IT, Diagnostic Equipment, Web Applications, Medical Software

Website

www.cii-tech.com

Verticals

Big Data, HealthTech, Mobile Apps

Company Stage

Angel & Seed

Total Amount Raised

Subscriber access only

Huayi Ningchuang - employee data

Blurred Background

Want to see Employee Count?

Request a demo for full access to this profile.

GoingPro

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.